View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Patients as Partners Speakers Collaborate on Inaugural Patient Engagement White Paper

  • November 16, 2016

  • patients-2017-whitepaper-authors

    From Left to Right: Marc Boutin (NHC), Jan Geissler (EUPATI), Roslyn Schneider (Pfizer), Tony Hoos (Amgen EU), Veronica Todaro (Parkinson’s Disease Foundation), Sarah Krüg (Cancer 101), Andrew Garvey (GSK)

    Patients as Partners EU and US speakers including Marc Boutin, National Health Council, Tony Hoos, Amgen EU, Andrew Garvey, GSK, Jan Geissler, EUPATI, Veronica Todaro, Parkinson’s Disease Foundation, Roslyn Schneider, Pfizer and Sarah Krüg, Cancer 101, collaborated on an inaugural white paper focusing on culture and process change as a priority for patient engagement.

    Patient Focused Medicine’s Development (PFMD) published the white paper this week in the peer reviewed journal Therapeutic Innovation & Regulatory Science (TIRS).

    The authors of the white paper are lead advisors to both Patients as Partners programs and will be participating in case studies and panel sessions at Patients as Partners Europe taking place February 6-7, 2017 in London and Patients as Partners US taking place March 2-3, 2017 in Philadelphia.

    Read the white paper here.

    For more information on Patients as Partners Europe, click here.

    For more information on Patients as Partners US, click here.